Clinical trial NCT05383248: Computational Cognitive Training To Boost Reward Responsiveness In Anhedonic Patients
Official title: Computational Cognitive Training To Boost Reward Responsiveness In Anhedonic Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Anhedonia
Depression
Lead sponsor: University of California, San Diego
Sponsor class: OTHER
First posted: 2022-05-20
Enrollment: 50
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Anhedonia, i.e., reduced positive mood and decreased sensitivity to rewards, is observed in many psychiatric illnesses, particularly depression and anxiety disorders. Untreated anhedonia predicts worse clinical outcomes and poorer response to treatment, yet cognitive behavioral treatment approaches to target anhedonia are fraught with poor patient compliance in real-life settings. The proposed study aims to address this gap by 1) testing the usefulness of a non-invasive, computationally informed, cognitive training in boosting reward sensitivity and reducing anhedonia in depressed and anxious patients, and 2) delineating the neurocomputational mechanisms of change associated with such intervention. In other words, can we train the brain to obtain rewards and boost positive mood among depressed and anxious individuals? This project will help to develop a computational training protocol aimed at reducing anhedonia and improving existing interventions for psychiatric conditions characterized by reward processing deficits. Long-term goals include expanding this framework to a broader range of appetitive and social stimuli to develop precise cognitive training tools to treat anhedonia.


Eligibility criteria: Inclusion Criteria:

* Age 18-65 (all races, both males and females will be included)
* Current diagnosis of Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD)
* A score \< 7 on the Snaith-Hamilton Pleasure Scale (SHAPS) or \< 25 on the Positive Affect subscale from the Positive And Negative Affect Scale (PANAS)
* Sufficient proficiency in English language to understand and complete informed consent, interviews, questionnaires, and all other study procedures.
* Having normal or corrected vision
* Having normal or corrected hearing

Exclusion Criteria:

* Endorsement of past or current psychotic or bipolar disorder.
* Endorsement of recent severe alcohol or substance use disorder (past 3 months).
* Inability to discontinue for 48 hours prior to scan any medications incompatible with measuring reliable/interpretable neural activity (e.g., e.g., benzodiazepines/beta-blockers, atypical anti-depressants, anxiolytics and sedative hypnotics, antipsychotics, and opioid analgesics)
* Being unsafe to undergo functional magnetic resonance imaging (fMRI), i.e., being pregnant, presence of non-removable metal in body, medical conditions that are incompatible with safe MRI (e.g., claustrophobia, inability to lie still on one's back for approximately 60 minutes; prior neurosurgery)
* Clinical conditions assessed by the interviewer that necessitate more imminent clinical care (e.g., active suicidal ideation): These criteria are in place so participants with these other, more several symptoms can be referred for appropriate mental health services.

Primary outcomes:
measure: Reward Maximization
timeFrame: Change between Pre-Training and Post-Training Assessments (about 20 min)
measure: Positive Affect
timeFrame: Change between Pre-Training and Post-Training Assessments (about 20 min)
measure: Neural Tracking of Reward Expectation
timeFrame: Change between Pre-Training and Post-Training Assessments (about 20 min)
Secondary outcomes:
Other outcomes:
Locations:
city: La Jolla
country: United States
facility: UCSD Center for Functional Magnetic Resonance Imaging
state: California
Study officials:
References: